AntaBio, The Wellcome Trust deal

AntaBio received a €1.7 million ($2.3 million) milestone payment from The Wellcome Trust under a 2013 deal to develop a small molecule pan-inhibitor of bacterial metallo-beta-lactamases to treat multi...